Chronic lymphocytic leukemia (CLL) is a B-cell malignancy, with disease progression ranging from slow and indolent to ...

The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...

Jim Richards doesn’t look like a mad scientist and his plant-based milk made from macadamia nuts tastes delicious. Yet his carefully crafted product is one of many in the grocery store that can fall ...

Migration to other parts of the world and leaving your homeland may not be easy for everyone, but it is situations and circumstances that make us do so. The migrant population is observed to be prone ...

In one of the most tense exchanges in a heated confirmation hearing, Senator Angela Alsobrooks called out past comments RFK ...

Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware ...

Houston, Texas, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Autoimmunity BioSolutions is proud to announce that it will be presenting at the upcoming Sequire Investor Summit 2025. The 2025 Edition of the ...

MOUNTAIN VIEW, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company committed to developing and delivering medicines to treat patients with ...

MOUNTAIN VIEW, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company committed to developing and delivering medicines to treat patients with ...

These results suggest glycolysis as a metabolic driver of IDEC-mediated inflammation in AD. Taken together, the contributions to the Research Topic “Key Players of the Immune System in Skin ...